Navigation Links
Reportlinker Adds the Drug-Eluting Stent Market Outlook to 2016
Date:4/20/2011

NEW YORK, April 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The Drug-Eluting Stent Market Outlook to 2016

http://www.reportlinker.com/p0483600/The-Drug-Eluting-Stent-Market-Outlook-to-2016.html

Introduction

The DES market has seen tremendous growth since the introduction of DES in 2003, but the market suffered setbacks in 2007 on the release of clinical data that indicated a link to increased thrombosis. Sales of DES have since stabilized owing to the introduction of novel stents with proven superior therapeutic properties over the traditional bare metal stent.

Features and benefits

* Assess the major market trends including mergers and acquisitions, and licensing agreements and their impact on the market.

* Identify the growth strategies of the leading market players and their likely impact on the future DES market.

* Identify key innovations that will shape the DES market of the future.

* Gain insight into the influence of the emerging economies in determining the present and future DES market size.

* Identify emerging companies that are likely to compete in the near future with the leading DES manufacturers.

Highlights

The DES market has been traditionally characterized by low levels of innovation. However, with the shift in hospital purchasing models from the current sole-supplier model to the capitation pricing model, innovative products are the only ones likely to command premium prices. Thus, this will increase the level of innovation in this segment.

The DES markets in India and China are set to undergo growth in the next five years, concurrent with the improvement of the economies of these two countries and the introduction of the 'Healthy China 2020' plan. However, leading players face stiff competition from local companies in these regions.

Hospitals are currently entering into preferred-supplier agreements whereby they source their medical device requirements from one or two preferred suppliers to leverage volume-based discounts. This puts large suppliers such as Boston Scientific in an advantageous position as they can cater to consolidated spend categories.

Your key questions answered

* What are the innovations being made in DES technology which of these offers significant potential for future growth?

* What are the key industry trends in terms of mergers and acquisitions and contractual and licensing agreements between buyers and suppliers?

* What are the key regulations in the DES segment and what is the possible impact of new DES technology on the product approval process?

* How have the leading players built a strong position in the DES market and what are their future growth strategies?

* Who are the emerging players in the DES market, what threat do they pose, and what are their business expansion strategies?

TABLE OF CONTENTS

Executive Summary

About Business Insights

Disclaimer

Overview of the global drug-eluting stents market

DES market landscape

Innovations in the DES market

Key players in the DES market

Overview of the global drug-eluting stents market

Summary

Introduction

Position of DES within the cardiac device market

Evolution of DES

Advantage of DES

Market size and forecasts of DES

Historical market size and forecasts

Geographical segmentation

Epidemiology of major cardiovascular diseases

Adoption trends in cardiovascular procedures

Growth drivers

Increased adoption by physicians owing to prevention of late in-stent restenosis

Decreased need for repeat procedures

Demographics – rise in the mean age of the population

Lifestyle changes – increased prevalence of obesity

Growth resistors

High cost of DES compared with BMS

Release of adverse clinical data pertaining to late stent thrombosis

Release of COURAGE data indicating no significant advantage of DES over BMS

Problems associated with Medicare reimbursement of DES

Regulatory changes impacting the DES market

DES market landscape

Summary

Introduction

Market trends

Mergers and acquisitions

Important mergers and acquisitions by leading players

Mergers, acquisitions, and co-exclusivity agreements among emerging players

Preferred supplier agreements

Increased importance of emerging countries

Pricing of DES

Historical prices of DES and trends

Future trends in pricing

Pricing in emerging economies

US Medicare Part A reimbursement costs of DES

Cost-effectiveness of DES versus BMS

Licensing agreements between pharmaceutical companies and DES manufacturers

Innovations in the DES market

Summary

Introduction

Factors driving innovation

Major innovations

Innovations in the polymer component of DES

Drug-coated balloons

Bifurcation stenting

Self-expandable DES

Development of DES with a two-drug offering

Drugs used in DES

New product approvals

FDA approvals

CE mark approvals

Pipeline

Nevo sirolimus-eluting stent (Johnson & Johnson)

Promus and Taxus everolimus-eluting element stents (Boston Scientific)

Taxus Petal paclitaxel-eluting stent (Boston Scientific)

Odyssey (Boston Scientific)

XIENCE Nano (Abbott labs)

Protex coronary stent system (Nexeon MedSystems)

CoroflexDEBlue stent (B. Braun Melsungen)

Key players in the DES market

Summary

Introduction

Relative positioning of the leading market participants

Boston Scientific

Abbott Laboratories

Cordis (Johnson & Johnson)

Medtronic

Product growth and share snapshot

Emerging players

Relative positioning of the emerging market participants

Opto Circuits

Sahajanand Medical Technologies

Blue Medical Devices

Biosensors International

Stentys

MicroPort Scientific

Orbus-Neich Medical

Appendix

Scope

Methodology

Glossary/Abbreviations

References

To order this report:

: The Drug-Eluting Stent Market Outlook to 2016

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Successful Strategies for Drug Repositioning
2. Reportlinker Adds Middle Eastern Medical Device Market: Facts and Figures2011
3. Reportlinker Adds Levosimendan - Comprehensive patent search
4. Reportlinker Adds Zolpidem - Key patent, SPC, and data exclusivity expiry (44 country coverage)
5. Reportlinker Adds North America Dental Devices Market Outlook to 2017
6. Reportlinker Adds ENT Devices Market Outlook in Brazil to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
7. Reportlinker Adds ENT Devices Market Outlook in United States to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
8. Reportlinker Adds Companion Diagnostics Partnering Terms and Agreements
9. Reportlinker Adds ENT Devices Market Outlook in China to 2017 - Hearing Aid Devices and Implants and Diagnostic Devices
10. Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
11. Reportlinker Adds Neurology Devices Market Outlook in United States to 2017 - Neurostimulation Devices, Interventional Neurology and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Dec. 6, 2016 Anaplastic Oligoastrocytoma - ... Markets Direct,s latest Pharmaceutical and Healthcare disease pipeline ... provides an overview of the Anaplastic Oligoastrocytoma (Oncology) ... tumor that forms when two types of cells ... increase in number to form a mass. These ...
(Date:12/6/2016)... 2016  Nearly 30 million people in ... of diabetes. 1 However, nearly 40% of diabetes ... (hyperglycemia) and significant glucose variability. 2 These patients are ... events. If left untreated, hyperglycemia can lead to cardiovascular ... blindness. 3 As part of Diabetes ...
(Date:12/6/2016)... 2016  Arcturus Therapeutics, Inc. ("Arcturus" or the ... that it entered into collaboration with Takeda Pharmaceutical ... treatment of NASH and other gastrointestinal (GI) related ... and UNA Oligomer chemistry. The financial terms were ... to and expertise in GI disorders, we are ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... One of two inventors from Glen Burnie, ... is painful for her. "This is why the co-inventor and I have designed a ... They then created a prototype of the patent-pending AV-AIR, a device that serves as ...
(Date:12/7/2016)... ... XX, 2016 (PRWEB) (PRWEB) December 07, 2016 , ... Man’s ... Filamentous Dermatitis Associated with Borrelia Infection” reveals that a condition similar ... the prestigious Journal of Veterinary Science & Medical Diagnosis. , Morgellons disease is ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... Facial plastic ... this holiday season by donating a portion of proceeds to two local organizations: North ... Chicago Animal Control & Friends is a team of authorized and trained volunteers ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live From won ... year’s best in pioneering, inventive, and ultimately successful projects undertaken by the media ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite ... Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on their ... experience. , BOC Global Events & Training Group is a professional event and ...
Breaking Medicine News(10 mins):